Differential preservation of lipopolysaccharide-induced chemokine/cytokine expression during experimental pancreatitis-associated organ failure in rats shows a regulatory expressed phenotype

Pancreatology

Volumn 8, Issue 4-5, 2008, Pages 478-487

  Mole, Damian J ^a,b,c   McFerran, Neil V ^b   Diamond, Thomas ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Lipopolysaccharide responsiveness; Multiple organ failure; Pancreatitis, acute

Indexed keywords

CERULETIDE; CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; FRACTALKINE; GAMMA INTERFERON; GLYCODEOXYCHOLIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FACTORIAL DESIGN; LAPAROTOMY; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PHENOTYPE; PRESERVATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

EID: 50549102848     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000151775     Document Type: Article

References (44)

1. Goldacre MJ, Roberts SE: Hospital admission for acute pancreatitis in an English population, 1963-1998: database study of incidence and mortality. BMJ 2004;328:1466-1469.
2. Johnson CD, Abu-Hilal M: Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004;53:1340-1344.
3. Andersson R, Andren-Sandberg A: Fatal acute pancreatitis. Characteristics of patients never reaching hospital. Pancreatology 2003;3:64-66.
4. Blum T, Maisonneuve P, Lowenfels AB, Lankisch PG: Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology 2001;1:237-241.
5. Buter A, Imrie CW, Carter CR, Evans S, McKay CJ: Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 2002;89:298-302.
6. McKay CJ, Buter A: Natural history of organ failure in acute pancreatitis. Pancreatology 2003;3:111-114.
7. Beutler B: Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004;430:257-263.
8. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, Chevali L: Pathophysiology of acute pancreatitis. Pancreatology 2005;5:132-144.
9. Hughes CB, Gaber LW, Kotb M, Mohey el-Din AB, Pabst M, Gaber AO: Induction of acute pancreatitis in germ-free rats: evidence of a primary role for tumor necrosis factor-alpha. Surgery 1995;117:201-205.
10. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
11. Beutler B: Sepsis begins at the interface of pathogen and host. Biochem Soc Trans 2001;29:853-859.
12. Oppenheim JJ, Feldmann M: Introduction to the role of cytokines in innate host defense and adaptive immunity; in Oppenheim JJ, Feldmann M (eds): Cytokine Reference Online. New York, Academic Press, 2002.
13. Uhl W, Isenmann R, Buchler MW: Infections complicating pancreatitis: diagnosing, treating, preventing. New Horiz 1998;6(suppl):S72-S79.
14. van Westerloo DJ, Schultz MJ, Bruno MJ, de Vos AF, Florquin S, van der Poll T: Acute pancreatitis in mice impairs bacterial clearance from the lungs, whereas concurrent pneumonia prolongs the course of pancreatitis. Crit Care Med 2004;32:1997-2001.
15. Abraham E, Freitas AA, Coutinho AA: Hemorrhage in mice produces alterations in B cell repertoires. Cell Immunol 1989;122:208-217.
16. Adib-Conquy M, Asehnoune K, Moine P, Cavaillon JM: Long-term-impaired expression of nuclear factor-kappa B and I kappa B alpha in peripheral blood mononuclear cells of trauma patients. J Leukoc Biol 2001;70:30-38.
17. Moore FA, Moore EE, Sauaia A: Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997;132:620-625.
18. Satoh A, Masamune A, Kimura K, Kaneko K, Sakai Y, Yamagiwa T, Satoh M, Kikuta K, Asakura T, Shimosegawa T: Nuclear factor kappa B expression in peripheral blood mononuclear cells of patients with acute pancreatitis. Pancreas 2003;26:350-356.
19. Kylanpaa ML, Mentula P, Kemppainen E, Puolakkainen P, Aittomaki S, Silvennoinen O, Haapiainen R, Repo H: Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro. Pancreas 2005;31:23-27.
20. Gray KD, Simovic MO, Chapman WC, Blackwell TS, Christman JW, May AK, Parman KS, Stain SC: Endotoxin potentiates lung injury in cerulein-induced pancreatitis. Am J Surg 2003;186:526-530.
21. Mole DJ, Taylor MA, McFerran NV, Diamond T: The isolated perfused liver response to a 'second hit' of portal endotoxin during severe acute pancreatitis. Pancreatology 2005;5:475-485.
22. Pastor CM, Pugin J, Kwak B, Chanson M, Mach F, Hadengue A, Frossard JL: Role of Toll-like receptor 4 on pancreatic and pulmonary injury in a mice model of acute pancreatitis associated with endotoxemia. Crit Care Med 2004;32:1759-1763.
23. van Westerloo DJ, Weijer S, Bruno MJ, de Vos AF, Van't Veer C, van der Poll T: Toll-like receptor 4 deficiency and acute pancreatitis act similarly in reducing host defense during murine Escherichia coli peritonitis. Crit Care Med 2005;33:1036-1043.
24. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, Warshaw AL: A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992;215:44-56.
25. Alsfasser G, Antoniu B, Thayer SP, Warshaw AL, Fernandez-del Castillo C: Degradation and inactivation of plasma tumor necrosis factor-alpha by pancreatic proteases in experimental acute pancreatitis. Pancreatology 2005;5:37-43.
26. Aderem A: Systems biology: its practice and challenges. Cell 2005;121:511-513.
27. Freudenberg MA, Keppler D, Galanos C: Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun 1986;51:891-895.
28. Dobrovolskaia MA, Vogel SN: Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002;4:903-914.
29. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005;365:63-78.
30. Czura CJ, Tracey KJ: Autonomic neural regulation of immunity. J Intern Med 2005;257:156-166.
31. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003;111:1805-1812.
32. Samols D, Agrawal A, Kushner I: Acute phase proteins; in Oppenheim JJ, Feldmann M (eds): Cytokine Reference Online. New York, Academic Press, 2002.
33. Ziegler-Heitbrock HW, Wedel A, Schraut W, Strobel M, Wendelgass P, Sternsdorf T, Bauerle PA, Haas JG, Riethmuller G: Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 1994;269:17001-17004.
34. Medvedev AE, Kopydlowski KM, Vogel SN: Inhibition of lipopolysaccharide- induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 2000;164:5564-5574.
35. Sato S, Nomura F, Kawai T, Takeuchi O, Muhlradt PF, Takeda K, Akira S: Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol 2000;165:7096-7101.
36. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk HD: Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med 1995;181:1887-1892.
37. Oppenheim JJ, Howard OMZ, Goetzl E: Chemotactic factors, neuropeptides, and other ligands for seven transmembrane receptors; in Oppenheim JJ, Feldmann M (eds): Cytokine Reference Online. New York, Academic Press, 2002.
38. Gerard C, Frossard JL, Bhatia M, Saluja A, Gerard NP, Lu B, Steer M: Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest 1997;100:2022-2027.
39. Bhatia M, Brady M, Zagorski J, Christmas SE, Campbell F, Neoptolemos JP, Slavin J: Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut 2000;47:838-844.
40. Greaves DR, Schall TJ: Fractalkine; in Oppenheim JJ, Feldmann M (eds): Cytokine Reference Online. New York, Academic Press, 2002.
41. Ito T: Can measurement of chemokines become useful biological and functional markers of early-stage chronic pancreatitis? J Gastroenterol 2007;42(suppl 17):72-77.
42. de Waal Malefyt R: IL-10; in Oppenheim JJ, Feldmann M (eds): Cytokine Reference Online. New York, Academic Press, 2002, pp 165-185.
43. Yang BM, Demaine AG, Kingsnorth A: Chemokines MCP-1 and RANTES in isolated rat pancreatic acinar cells treated with CCK and ethanol in vitro. Pancreas 2000;21:22-31.
44. Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, Webb GR, Martin MU, Mantovani A, Muzio M: Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 2002;99:3427-3431.